ID   LNCaP C4-2Pr
AC   CVCL_6E93
SY   C4-2Pr; C4-2 Pr; C4-2 Primary tumor
DR   cancercelllines; CVCL_6E93
DR   Wikidata; Q54902821
RX   PubMed=8168083;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; 644; AR; Simple; p.Thr878Ala (c.2632A>G); ClinVar=VCV000009831; Zygosity=Hemizygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; 7010; MEN1; Simple; p.Tyr318Ter (c.954T>G) (p.Tyr313Ter, c.939T>A); ClinVar=VCV000439894; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; 8979; PIK3R1; Simple; p.Arg639Ter (c.1915C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; 9588; PTEN; Simple; p.Lys6Argfs*4 (c.17_18delAA); ClinVar=VCV000231649; Zygosity=Unspecified (from parent cell line).
CC   Derived from site: Metastatic; Left supraclavicular lymph node; UBERON=UBERON_8480056.
DI   NCIt; C4863; Prostate carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_4782 ! LNCaP C4-2
SX   Male
AG   50Y
CA   Cancer cell line
DT   Created: 23-02-16; Last updated: 05-10-23; Version: 12
//
RX   PubMed=8168083;
RA   Thalmann G.N., Anezinis P.E., Chang S.-M., Zhau H.-Y.E., Kim E.E.,
RA   Hopwood V.L., Pathak S., von Eschenbach A.C., Chung L.W.K.;
RT   "Androgen-independent cancer progression and bone metastasis in the
RT   LNCaP model of human prostate cancer.";
RL   Cancer Res. 54:2577-2581(1994).
//